Literature DB >> 25152980

Kupffer cells: increasingly significant role in nonalcoholic fatty liver disease.

Zhang Wenfeng1, Wu Yakun2, Mu Di3, Gong Jianping1, Wu Chuanxin1, Huang Chun4.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is considered to be a manifestation of liver metabolic damage and is related to insulin resistance and genetic susceptibility. Inflammation mediated by Kupffer cells (KCs) is of critical importance to the development of NAFLD. The primary role of KCs in NAFLD is considered to be the perturbation of the C-Jun N-terminal kinase (JNK) and nuclear factor-kappa B (NF-κB) pathways as a result of lipopolysaccharide (LPS) recognition by Toll-like receptor 4 (TLR4). Simultaneously, the activation of NF-κB, as mediated by oxidative and endoplasmic reticulum (ER) stress and free fatty acid (FFA) or free cholesterol (FC) crystal formation, heavily relies on NF-κB regulatory factors and TLR4. Additionally, the imbalance of certain pro-inflammatory cytokines and chemokines released by innate immunity is deemed to promote the steatosis of hepatocytes. In conclusion, this review indicates that the inflammatory and oxidative stress of KCs play a significant role in the development of NAFLD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25152980

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  39 in total

1.  STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis.

Authors:  Yongsheng Yu; Yu Liu; Weishuai An; Jingwen Song; Yuefan Zhang; Xianxian Zhao
Journal:  J Clin Invest       Date:  2018-12-18       Impact factor: 14.808

Review 2.  Effects of red wine on postprandial stress: potential implication in non-alcoholic fatty liver disease development.

Authors:  Ilaria Peluso; Husseen Manafikhi; Raffaella Reggi; Maura Palmery
Journal:  Eur J Nutr       Date:  2015-03-16       Impact factor: 5.614

Review 3.  Preclinical models of non-alcoholic fatty liver disease.

Authors:  Prasanna K Santhekadur; Divya P Kumar; Arun J Sanyal
Journal:  J Hepatol       Date:  2017-11-09       Impact factor: 25.083

Review 4.  Pathogenesis of nonalcoholic steatohepatitis.

Authors:  Wensheng Liu; Robert D Baker; Tavleen Bhatia; Lixin Zhu; Susan S Baker
Journal:  Cell Mol Life Sci       Date:  2016-02-19       Impact factor: 9.261

Review 5.  IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression.

Authors:  Daniel A Giles; Maria E Moreno-Fernandez; Senad Divanovic
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

6.  Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease.

Authors:  Maria E Moreno-Fernandez; Daniel A Giles; Traci E Stankiewicz; Rachel Sheridan; Rebekah Karns; Monica Cappelletti; Kristin Lampe; Rajib Mukherjee; Christian Sina; Anthony Sallese; James P Bridges; Simon P Hogan; Bruce J Aronow; Kasper Hoebe; Senad Divanovic
Journal:  JCI Insight       Date:  2018-03-22

7.  Phytosterols Synergize With Endotoxin to Augment Inflammation in Kupffer Cells but Alone Have Limited Direct Effect on Hepatocytes.

Authors:  Gregory Guthrie; Bryan Tackett; Barbara Stoll; Camilia Martin; Oluyinka Olutoye; Douglas G Burrin
Journal:  JPEN J Parenter Enteral Nutr       Date:  2017-12-11       Impact factor: 4.016

8.  PI3K inhibition protects mice from NAFLD by down-regulating CMKLR1 and NLRP3 in Kupffer cells.

Authors:  Wenfeng Zhang; Yan Liu; Mingbing Wu; Xiwen Zhu; Tao Wang; Kun He; Peizhi Li; Xiaoling Wu
Journal:  J Physiol Biochem       Date:  2017-09-13       Impact factor: 4.158

9.  Macrophages in Nonalcoholic Steatohepatitis: Friend or Foe?

Authors:  Joel Grunhut; Wei Wang; Berk Aykut; Inderdeep Gakhal; Alejandro Torres-Hernandez; George Miller
Journal:  Eur Med J Hepatol       Date:  2018-05-31

10.  Amitriptyline inhibits nonalcoholic steatohepatitis and atherosclerosis induced by high-fat diet and LPS through modulation of sphingolipid metabolism.

Authors:  Zhongyang Lu; Yanchun Li; Wing-Kin Syn; Zhewu Wang; Maria F Lopes-Virella; Timothy J Lyons; Yan Huang
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-12-10       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.